BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/4/2014 2:06:00 PM | Browse: 1361 | Download: 822
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 2324
Country United Kingdom
Received
2013-02-17 08:57
Peer-Review Started
2013-02-17 10:28
To Make the First Decision
2013-03-18 15:54
Return for Revision
2013-03-25 09:31
Revised
2013-03-26 22:05
Second Decision
2013-04-10 16:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-04-11 05:24
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-06-04 14:01
Publish the Manuscript Online
2013-06-13 17:10
ISSN 1948-5204 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title RAS signaling pathways, mutations and their role in colorectal cancer
Manuscript Source Invited Manuscript
All Author List Kypros Zenonos and Katy Kyprianou
Funding Agency and Grant Number
Corresponding Author Dr. Kypros Zenonos, College of Medical and Dental Sciences, University of Birmingham, Flat 2, 250 High Street, Birmingham B17 9PT, United Kingdom. kxz908@bham.ac.uk
Key Words Genes; RAS; Colorectal neoplasms; Therapeutics; Mitogen-activated protein kinase signaling system
Core Tip This review outlines clearly the normal function of the mitogen-activated protein kinases and phosphoinositide-3 kinase cascades, in which the RAS proto-oncogene operates physiologically. It also describes the mutations in these pathways that lead to colorectal cancer (CRC), as well as other mutations outside these cascades affecting RAS function and also leading to CRC. The prognostic value of each mutation is assessed and linked to response rates to available biological treatments. Monoclonal antibodies under development are also briefly discussed.
Publish Date 2013-06-13 17:10
Citation Zenonos K, Kyprianou K. RAS signaling pathways, mutations and their role in colorectal cancer. World J Gastrointest Oncol 2013; 5(5): 97-101
URL http://www.wjgnet.com/1948-5204/full/v5/i5/97.htm
DOI http://dx.doi.org/10.4251/wjgo.v5.i5.97
Full Article (PDF) WJGO-5-97.pdf
Manuscript File 2324-Review.docx
Answering Reviewers 2324-Answering reviewers.pdf
Copyright License Agreement 2324-Copyright assignment.pdf
Peer-review Report 2324-Peer review.pdf
Scientific Editor Work List 2324-Scientific editor work list.doc